Our analysis revealed that in addition to being expressed in a specific subset of endothelial cells post-stroke, CCL19 exhibited low baseline expression predominantly in stromal cells under normal conditions (Fig. S17A, B). This evidence concerns the gene CCL19 and stroke disorder.